Supply and Use Sample Clauses
The 'Supply and Use' clause defines the obligations and rights regarding the provision and utilization of goods, services, or resources under an agreement. It typically outlines what each party is required to supply, the standards or specifications to be met, and how the supplied items or services may be used by the receiving party. For example, it may specify delivery timelines, permitted uses, or restrictions on redistribution. This clause ensures both parties have a clear understanding of their responsibilities and the intended use of supplied items, thereby reducing the risk of disputes and misuse.
Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no cost. Institution and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and securely-locked area as per Protocol requirements; (iii) will use Study Drug only for Study purposes and according to the Protocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the Study Drug or any portion thereof to any third party without first obtaining written approval from Idorsia.
Supply and Use. Actelion owns or has the necessary rights to the Study Drug. Actelion or its corporate affiliate will provide the Study Drug to Provider at no cost. Provider (i) will verify to Actelion receipt of the Study Drug; (ii) will store the Study Drug in a safe and securely-locked area per Protocol requirements; (iii) will use Study Drug only for Study purposes and according to the Protocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the Study Drug or any portion thereof to any third party without first obtaining written approval from Actelion.
1.6.1 Dodání a užívání. Společnost Actelion vlastní Hodnocený přípravek nebo má k němu všechna nezbytná práva. Společnost Actelion nebo její spřízněná společnost poskytne bezúplatně Poskytovateli Hodnocený přípravek. Poskytovatel (i) potvrdí společnosti Actelion převzetí Hodnoceného přípravku; (ii) uchovává Hodnocený přípravek na bezpečném a bezpečně uzamčeném místě v souladu s požadavky Protokolu; (iii) užívá Hodnocený přípravek výhradně pro účely provádění Klinického hodnocení a v souladu s Protokolem; (iv) omezí přístup k Hodnocenému přípravku pouze na ty Pracovníky podílející se na klinickém hodnocení, kteří jsou pod přímou kontrolou Zkoušejícího; (v) nevydává Subjektům expirovaný Hodnocený přípravek; a
Supply and Use. Idorsia owns or has the necessary rights to the Study Drug. Idorsia or its corporate affiliate will provide the Study Drug to Institution at no cost. Institu- tion and Investigator; (i) will verify to Idorsia receipt of the Study Drug; (ii) will store the Study Drug in a safe and se- curely-locked area as per Protocol require- ments; (iii) will use Study Drug only for Study purposes and according to the Pro- tocol; (iv) will limit access to the Study Drug only to those Study Personnel who 1.7
Supply and Use. Actelion owns or has the necessary rights to the Study Drug. Actelion or its corporate affiliate will provide the Study Drug to Institution at no cost. Institution and Investigator; (i) will verify to Actelion receipt of the Study Drug; (ii) will store the Study Drug in a safe and securely- locked area per Protocol requirements; (iii) will use Study Drug only for Study purposes
Supply and Use. The Provider shall supply the Material and the Provider Know-how to the Recipient at the premises of the Recipient. Risk in the Material [and the Provider Know-how] shall pass to the Recipient on delivery. The Recipient shall: only use the Material, Provider IPR and Provider Know-how for the Purpose during the Term in compliance with good laboratory practice, the highest standards of skill and care and all applicable laws and regulations [and the Provider's instructions concerning storage and use of the Materials]; ensure that the personnel handling the Material are apprised of any known hazards and warrants that they are qualified by training and experience to perform the Purpose; the Material is not for use in humans, in clinical trials, or for diagnostic purposes involving human subjects without the written consent of the Provider; the Recipient will not use any of the Materials for any commercial purpose or commercially-sponsored research without the prior written consent of the Provider which consent may be granted at the Provider’s sole discretion; and the Material is not to be given or made available to any third party or person, except Recipient’s employees, consultants, contract research organizations or collaborators that are bound by terms and conditions similar to the terms and conditions that are contained herein and shall not be used for any purpose other than for the Purpose. All requests for the Material from a third party other than Recipient’s employees, consultants, contract research organizations or collaborators will be referred to the Provider.
Supply and Use. Actelion owns or has the necessary rights to the Study Drug. Actelion or its corporate affiliate will provide the Study Drug to Institution at no cost. Institution and Investigator; (i) will verify to Actelion receipt of the Study Drug; (ii) will store the Study Drug in a safe and securely- locked area per Protocol requirements; (iii) will use Study Drug only for Study purposes and according to the Protocol; (iv) will limit access to the Study Drug only to those Study Personnel who are under Investigator's direct control; (v) will not dispense expired Study Drug to Subjects; and (vi) will not transfer the Study Drug or any portion thereof to any third party without first obtaining written approval from Actelion.
Supply and Use